A New Human Blood-Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes

The blood-retinal barrier (BRB) is a critical structure that maintains retinal homeostasis. Dysfunction of this barrier is a hallmark of diabetic retinopathy. Prior research has shown that high glucose levels can disrupt BRB integrity, but the exact mechanisms remain unclear. Existing in vitro models often fail to replicate the complex interactions among retinal cell types. This gap motivated the development of a more accurate model. No prior work had resolved the need for a human-based triple co-culture system. This paper's contribution lies in its use of retinal endothelial cells, pericytes, and astrocytes in a defined ratio. The model aims to better reflect the in vivo human retinal environment. This approach allows for a more precise investigation of BRB disruption under diabetic conditions.

The study aimed to establish a reproducible in vitro model of the human blood-retinal barrier. The goal was to replicate the in vivo cell composition and layering of retinal endothelial cells, pericytes, and astrocytes. The researchers sought to investigate how high glucose exposure affects BRB function. They wanted to determine whether this model could detect changes in permeability and junction protein levels. The motivation was to improve understanding of diabetic retinopathy mechanisms. The model was also intended to serve as a platform for testing potential therapeutic agents. This approach could help identify new targets for intervention. The study's focus was on the role of oxidative stress and inflammation in BRB dysfunction.

The researchers used retinal endothelial cells, pericytes, and astrocytes obtained from human tissue. These cells were cultured in a defined numerical ratio and layer order to mimic the in vivo BRB structure. The model was exposed to high glucose conditions to simulate diabetic environments. Permeability was measured using standard in vitro assays. Levels of junction proteins such as ZO-1 and VE-cadherin were analyzed using immunofluorescence. Pro-inflammatory mediators and oxidative stress markers were quantified via ELISA and Western blot. Reactive oxygen species production was assessed using fluorescent probes. The model's response to high glucose was compared to control conditions.

Exposure to high glucose significantly increased BRB permeability in the model. Levels of ZO-1 and VE-cadherin were reduced, indicating junctional disruption. Pro-inflammatory mediators like IL-1β and IL-6 were upregulated. Oxidative stress enzymes such as iNOS and Nox2 showed increased expression. Reactive oxygen species production was elevated in the high-glucose condition. The Nrf2 and HO-1 signaling pathways were activated in response to stress. These findings suggest a link between high glucose and BRB dysfunction. The model effectively replicated key features of diabetic retinopathy.

The study concludes that the triple co-culture model closely mimics the human in vivo BRB environment. The model demonstrated that high glucose exposure disrupts barrier integrity. The observed changes in junction proteins and inflammatory markers support prior findings. The activation of Nrf2 and HO-1 pathways suggests a compensatory response. The model provides a valuable tool for studying diabetic retinopathy mechanisms. It can be used to test the effects of potential therapeutic agents. The findings align with the authors' hypothesis about BRB dysfunction in diabetes. The model's reproducibility supports its use in future studies.